Head-to-head · WeighScore
GoodRx vs NuviaRx
The verdict
NuviaRx takes it — 73.5/100 to 69.6/100.
NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | GoodRx | NuviaRx |
|---|---|---|
| WeighScore | 69.6/100 | 73.5/100 |
| Grade | C | C |
| Scorecard rank | #125 | #72 |
| Semaglutide | Not disclosed | $140/mo (all doses, compounded) |
| Tirzepatide | $299/mo (brand Zepbound) | $170/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #125 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Graded #72 · C
Strengths
- Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
- Free delivery included; clinical evaluation and prescription bundled (if eligible)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
- Named operating entity (NuviaRx Health Inc.) with a US address and phone support
Where it loses points
- Compounding pharmacy partner not named ('partner pharmacy')
- Not LegitScript-certified (no certification displayed)
- Lowest pricing is 'as low as' — likely requires a longer prepaid plan
- State availability not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.